10,000 Re-Randomization Sequences Confirm Simponi Efficacy Results
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Centocor demonstrated that an adaptive randomization technique provided comparable results to conventional randomization during pivotal trials for Simponi (golimumab)